Price Alert

Biodexa Pharmaceuticals (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

6.67

0.06 (0.91%)

At close: Oct 02, 2025, 3:59 PM

6.61

-0.90%

After-hours: Oct 02, 2025, 06:22 PM EDT

0.91% (1D)

Bid	4.88
Market Cap	20
Revenue (ttm)	n/a
Net Income (ttm)	-5.73M
EPS (ttm)	-28.17
PE Ratio (ttm)	-0.24
Forward PE	n/a
Analyst	n/a
Dividends	n/a

Ask	8.64
Volume	8,873
Avg. Volume (20D)	70,293
Open	6.75
Previous Close	6.61
Day's Range	6.65 - 6.81
52-Week Range	5.00 - 108.90
Beta	0.87
Ex-Dividend Date	n/a

About BDRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BDRX

Website n/a

Full Company Profile

Why Price Moved

2 months ago

+12.13%

Biodexa Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription

3 months ago

+29.4%

Biodexa shares are trading higher after the company enrolled the first patient in its Phase 2a study of Tolimidone.

News

1 month ago · zacks.com

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock?

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 months ago · accessnewswire.com

How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable Market

CARDIFF, UK / ACCESS Newswire / July 28, 2025 / Familial Adenomatous Polyposis (FAP) is an inherited condition that puts people at a much greater risk of developing colon cancer. If left untreated, th...